カテゴリ： 世界, 医療/バイオ, QYResearch

オセルタミビルリン酸塩カプセルの世界市場2023年：30mg、45mg、75mg

■ 英語タイトル：Global Oseltamivir Phosphate Capsules Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA7522）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA7522
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：102
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[オセルタミビルリン酸塩カプセルの世界市場2023年：30mg、45mg、75mg]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

本調査資料はオセルタミビルリン酸塩カプセルのグローバル市場について調査・分析し、世界のオセルタミビルリン酸塩カプセル市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（30mg、45mg、75mg）、用途別セグメント分析（インフルエンザ治療、インフルエンザ予防）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Natco Pharma、Roche Pharma、HEC、Zentiva、Taj Pharma、Sawai Pharmaceutical、MSN Laboratories、Hetero Healthcare、Cipla、Amneal Pharmaceuticals、Brilliant Pharmaceutical、BrightGene、Kelun Pharmaceutical、Qilu Pharmaceutical、CSPC、Zhijun Pingshan、Zhongxi Sunveなどが含まれています。オセルタミビルリン酸塩カプセルのグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、オセルタミビルリン酸塩カプセル市場規模を算出する際に考慮しました。

・オセルタミビルリン酸塩カプセル市場の概要
- 製品の定義
- オセルタミビルリン酸塩カプセルの種類別セグメント
- 世界のオセルタミビルリン酸塩カプセル市場規模：タイプ別分析（30mg、45mg、75mg）
- オセルタミビルリン酸塩カプセルの用途別セグメント
- 世界のオセルタミビルリン酸塩カプセル市場規模：用途別分析（インフルエンザ治療、インフルエンザ予防）
- 世界のオセルタミビルリン酸塩カプセル市場規模予測（2018年-2029年）
- オセルタミビルリン酸塩カプセルの平均価格推移（2018年-2029年）
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- オセルタミビルリン酸塩カプセル市場の競争状況およびトレンド

・オセルタミビルリン酸塩カプセルの地域別市場規模
- 北米のオセルタミビルリン酸塩カプセル市場規模（2018年-2029年）
- 米国のオセルタミビルリン酸塩カプセル市場規模（2018年-2029年）
- ヨーロッパのオセルタミビルリン酸塩カプセル市場規模（2018年-2029年）
- アジア太平洋のオセルタミビルリン酸塩カプセル市場規模（2018年-2029年）
- 中国のオセルタミビルリン酸塩カプセル市場規模（2018年-2029年）
- 日本のオセルタミビルリン酸塩カプセル市場規模（2018年-2029年）
- 韓国のオセルタミビルリン酸塩カプセル市場規模（2018年-2029年）
- インドのオセルタミビルリン酸塩カプセル市場規模（2018年-2029年）
- オーストラリアのオセルタミビルリン酸塩カプセル市場規模（2018年-2029年）
- 中南米のオセルタミビルリン酸塩カプセル市場規模（2018年-2029年）
- 中東・アフリカのオセルタミビルリン酸塩カプセル市場規模（2018年-2029年）

・種類別セグメント：30mg、45mg、75mg
- 世界のオセルタミビルリン酸塩カプセルのタイプ別販売量（2018年-2023年）
- 世界のオセルタミビルリン酸塩カプセルのタイプ別売上（2018年-2023年）
- 世界のオセルタミビルリン酸塩カプセルのタイプ別価格

・用途別セグメント：インフルエンザ治療、インフルエンザ予防
- 世界のオセルタミビルリン酸塩カプセルの用途別販売量（2018年-2023年）
- 世界のオセルタミビルリン酸塩カプセルの用途別売上（2018年-2023年）
- 世界のオセルタミビルリン酸塩カプセルの用途別価格

・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向
Natco Pharma、Roche Pharma、HEC、Zentiva、Taj Pharma、Sawai Pharmaceutical、MSN Laboratories、Hetero Healthcare、Cipla、Amneal Pharmaceuticals、Brilliant Pharmaceutical、BrightGene、Kelun Pharmaceutical、Qilu Pharmaceutical、CSPC、Zhijun Pingshan、Zhongxi Sunve

・産業チェーンと販売チャネルの分析
- オセルタミビルリン酸塩カプセル産業チェーン分析
- オセルタミビルリン酸塩カプセルの主要原材料
- オセルタミビルリン酸塩カプセルの販売チャネル
- オセルタミビルリン酸塩カプセルのディストリビューター
- オセルタミビルリン酸塩カプセルの主要顧客

・オセルタミビルリン酸塩カプセル市場ダイナミクス
- オセルタミビルリン酸塩カプセルの業界動向
- オセルタミビルリン酸塩カプセル市場の成長ドライバ、課題、阻害要因

・調査の結論

・調査手法と情報源

Highlights
The global Oseltamivir Phosphate Capsules market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Oseltamivir Phosphate Capsules is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Oseltamivir Phosphate Capsules is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Oseltamivir Phosphate Capsules include Natco Pharma, Roche Pharma, HEC, Zentiva, Taj Pharma, Sawai Pharmaceutical, MSN Laboratories, Hetero Healthcare and Cipla, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Oseltamivir Phosphate Capsules, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oseltamivir Phosphate Capsules.
The Oseltamivir Phosphate Capsules market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Oseltamivir Phosphate Capsules market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oseltamivir Phosphate Capsules manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Natco Pharma
Roche Pharma
HEC
Zentiva
Taj Pharma
Sawai Pharmaceutical
MSN Laboratories
Hetero Healthcare
Cipla
Amneal Pharmaceuticals
Brilliant Pharmaceutical
BrightGene
Kelun Pharmaceutical
Qilu Pharmaceutical
CSPC
Zhijun Pingshan
Zhongxi Sunve
Segment by Type
30mg
45mg
75mg
Segment by Application
Influenza Treatment
Influenza Prevention
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Oseltamivir Phosphate Capsules manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Oseltamivir Phosphate Capsules in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Oseltamivir Phosphate Capsules Market Overview
1.1 Product Overview and Scope of Oseltamivir Phosphate Capsules
1.2 Oseltamivir Phosphate Capsules Segment by Type
1.2.1 Global Oseltamivir Phosphate Capsules Market Value Comparison by Type (2023-2029)
1.2.2 30mg
1.2.3 45mg
1.2.4 75mg
1.3 Oseltamivir Phosphate Capsules Segment by Application
1.3.1 Global Oseltamivir Phosphate Capsules Market Value by Application: (2023-2029)
1.3.2 Influenza Treatment
1.3.3 Influenza Prevention
1.4 Global Oseltamivir Phosphate Capsules Market Size Estimates and Forecasts
1.4.1 Global Oseltamivir Phosphate Capsules Revenue 2018-2029
1.4.2 Global Oseltamivir Phosphate Capsules Sales 2018-2029
1.4.3 Global Oseltamivir Phosphate Capsules Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Oseltamivir Phosphate Capsules Market Competition by Manufacturers
2.1 Global Oseltamivir Phosphate Capsules Sales Market Share by Manufacturers (2018-2023)
2.2 Global Oseltamivir Phosphate Capsules Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Oseltamivir Phosphate Capsules Average Price by Manufacturers (2018-2023)
2.4 Global Oseltamivir Phosphate Capsules Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Oseltamivir Phosphate Capsules, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Oseltamivir Phosphate Capsules, Product Type & Application
2.7 Oseltamivir Phosphate Capsules Market Competitive Situation and Trends
2.7.1 Oseltamivir Phosphate Capsules Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Oseltamivir Phosphate Capsules Players Market Share by Revenue
2.7.3 Global Oseltamivir Phosphate Capsules Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Oseltamivir Phosphate Capsules Retrospective Market Scenario by Region
3.1 Global Oseltamivir Phosphate Capsules Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Oseltamivir Phosphate Capsules Global Oseltamivir Phosphate Capsules Sales by Region: 2018-2029
3.2.1 Global Oseltamivir Phosphate Capsules Sales by Region: 2018-2023
3.2.2 Global Oseltamivir Phosphate Capsules Sales by Region: 2024-2029
3.3 Global Oseltamivir Phosphate Capsules Global Oseltamivir Phosphate Capsules Revenue by Region: 2018-2029
3.3.1 Global Oseltamivir Phosphate Capsules Revenue by Region: 2018-2023
3.3.2 Global Oseltamivir Phosphate Capsules Revenue by Region: 2024-2029
3.4 North America Oseltamivir Phosphate Capsules Market Facts & Figures by Country
3.4.1 North America Oseltamivir Phosphate Capsules Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Oseltamivir Phosphate Capsules Sales by Country (2018-2029)
3.4.3 North America Oseltamivir Phosphate Capsules Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Oseltamivir Phosphate Capsules Market Facts & Figures by Country
3.5.1 Europe Oseltamivir Phosphate Capsules Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Oseltamivir Phosphate Capsules Sales by Country (2018-2029)
3.5.3 Europe Oseltamivir Phosphate Capsules Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Oseltamivir Phosphate Capsules Market Facts & Figures by Country
3.6.1 Asia Pacific Oseltamivir Phosphate Capsules Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Oseltamivir Phosphate Capsules Sales by Country (2018-2029)
3.6.3 Asia Pacific Oseltamivir Phosphate Capsules Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Oseltamivir Phosphate Capsules Market Facts & Figures by Country
3.7.1 Latin America Oseltamivir Phosphate Capsules Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Oseltamivir Phosphate Capsules Sales by Country (2018-2029)
3.7.3 Latin America Oseltamivir Phosphate Capsules Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Oseltamivir Phosphate Capsules Market Facts & Figures by Country
3.8.1 Middle East and Africa Oseltamivir Phosphate Capsules Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Oseltamivir Phosphate Capsules Sales by Country (2018-2029)
3.8.3 Middle East and Africa Oseltamivir Phosphate Capsules Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Oseltamivir Phosphate Capsules Sales by Type (2018-2029)
4.1.1 Global Oseltamivir Phosphate Capsules Sales by Type (2018-2023)
4.1.2 Global Oseltamivir Phosphate Capsules Sales by Type (2024-2029)
4.1.3 Global Oseltamivir Phosphate Capsules Sales Market Share by Type (2018-2029)
4.2 Global Oseltamivir Phosphate Capsules Revenue by Type (2018-2029)
4.2.1 Global Oseltamivir Phosphate Capsules Revenue by Type (2018-2023)
4.2.2 Global Oseltamivir Phosphate Capsules Revenue by Type (2024-2029)
4.2.3 Global Oseltamivir Phosphate Capsules Revenue Market Share by Type (2018-2029)
4.3 Global Oseltamivir Phosphate Capsules Price by Type (2018-2029)
5 Segment by Application
5.1 Global Oseltamivir Phosphate Capsules Sales by Application (2018-2029)
5.1.1 Global Oseltamivir Phosphate Capsules Sales by Application (2018-2023)
5.1.2 Global Oseltamivir Phosphate Capsules Sales by Application (2024-2029)
5.1.3 Global Oseltamivir Phosphate Capsules Sales Market Share by Application (2018-2029)
5.2 Global Oseltamivir Phosphate Capsules Revenue by Application (2018-2029)
5.2.1 Global Oseltamivir Phosphate Capsules Revenue by Application (2018-2023)
5.2.2 Global Oseltamivir Phosphate Capsules Revenue by Application (2024-2029)
5.2.3 Global Oseltamivir Phosphate Capsules Revenue Market Share by Application (2018-2029)
5.3 Global Oseltamivir Phosphate Capsules Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Natco Pharma
6.1.1 Natco Pharma Corporation Information
6.1.2 Natco Pharma Description and Business Overview
6.1.3 Natco Pharma Oseltamivir Phosphate Capsules Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Natco Pharma Oseltamivir Phosphate Capsules Product Portfolio
6.1.5 Natco Pharma Recent Developments/Updates
6.2 Roche Pharma
6.2.1 Roche Pharma Corporation Information
6.2.2 Roche Pharma Description and Business Overview
6.2.3 Roche Pharma Oseltamivir Phosphate Capsules Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Roche Pharma Oseltamivir Phosphate Capsules Product Portfolio
6.2.5 Roche Pharma Recent Developments/Updates
6.3 HEC
6.3.1 HEC Corporation Information
6.3.2 HEC Description and Business Overview
6.3.3 HEC Oseltamivir Phosphate Capsules Sales, Revenue and Gross Margin (2018-2023)
6.3.4 HEC Oseltamivir Phosphate Capsules Product Portfolio
6.3.5 HEC Recent Developments/Updates
6.4 Zentiva
6.4.1 Zentiva Corporation Information
6.4.2 Zentiva Description and Business Overview
6.4.3 Zentiva Oseltamivir Phosphate Capsules Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Zentiva Oseltamivir Phosphate Capsules Product Portfolio
6.4.5 Zentiva Recent Developments/Updates
6.5 Taj Pharma
6.5.1 Taj Pharma Corporation Information
6.5.2 Taj Pharma Description and Business Overview
6.5.3 Taj Pharma Oseltamivir Phosphate Capsules Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Taj Pharma Oseltamivir Phosphate Capsules Product Portfolio
6.5.5 Taj Pharma Recent Developments/Updates
6.6 Sawai Pharmaceutical
6.6.1 Sawai Pharmaceutical Corporation Information
6.6.2 Sawai Pharmaceutical Description and Business Overview
6.6.3 Sawai Pharmaceutical Oseltamivir Phosphate Capsules Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Sawai Pharmaceutical Oseltamivir Phosphate Capsules Product Portfolio
6.6.5 Sawai Pharmaceutical Recent Developments/Updates
6.7 MSN Laboratories
6.6.1 MSN Laboratories Corporation Information
6.6.2 MSN Laboratories Description and Business Overview
6.6.3 MSN Laboratories Oseltamivir Phosphate Capsules Sales, Revenue and Gross Margin (2018-2023)
6.4.4 MSN Laboratories Oseltamivir Phosphate Capsules Product Portfolio
6.7.5 MSN Laboratories Recent Developments/Updates
6.8 Hetero Healthcare
6.8.1 Hetero Healthcare Corporation Information
6.8.2 Hetero Healthcare Description and Business Overview
6.8.3 Hetero Healthcare Oseltamivir Phosphate Capsules Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Hetero Healthcare Oseltamivir Phosphate Capsules Product Portfolio
6.8.5 Hetero Healthcare Recent Developments/Updates
6.9 Cipla
6.9.1 Cipla Corporation Information
6.9.2 Cipla Description and Business Overview
6.9.3 Cipla Oseltamivir Phosphate Capsules Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Cipla Oseltamivir Phosphate Capsules Product Portfolio
6.9.5 Cipla Recent Developments/Updates
6.10 Amneal Pharmaceuticals
6.10.1 Amneal Pharmaceuticals Corporation Information
6.10.2 Amneal Pharmaceuticals Description and Business Overview
6.10.3 Amneal Pharmaceuticals Oseltamivir Phosphate Capsules Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Amneal Pharmaceuticals Oseltamivir Phosphate Capsules Product Portfolio
6.10.5 Amneal Pharmaceuticals Recent Developments/Updates
6.11 Brilliant Pharmaceutical
6.11.1 Brilliant Pharmaceutical Corporation Information
6.11.2 Brilliant Pharmaceutical Oseltamivir Phosphate Capsules Description and Business Overview
6.11.3 Brilliant Pharmaceutical Oseltamivir Phosphate Capsules Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Brilliant Pharmaceutical Oseltamivir Phosphate Capsules Product Portfolio
6.11.5 Brilliant Pharmaceutical Recent Developments/Updates
6.12 BrightGene
6.12.1 BrightGene Corporation Information
6.12.2 BrightGene Oseltamivir Phosphate Capsules Description and Business Overview
6.12.3 BrightGene Oseltamivir Phosphate Capsules Sales, Revenue and Gross Margin (2018-2023)
6.12.4 BrightGene Oseltamivir Phosphate Capsules Product Portfolio
6.12.5 BrightGene Recent Developments/Updates
6.13 Kelun Pharmaceutical
6.13.1 Kelun Pharmaceutical Corporation Information
6.13.2 Kelun Pharmaceutical Oseltamivir Phosphate Capsules Description and Business Overview
6.13.3 Kelun Pharmaceutical Oseltamivir Phosphate Capsules Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Kelun Pharmaceutical Oseltamivir Phosphate Capsules Product Portfolio
6.13.5 Kelun Pharmaceutical Recent Developments/Updates
6.14 Qilu Pharmaceutical
6.14.1 Qilu Pharmaceutical Corporation Information
6.14.2 Qilu Pharmaceutical Oseltamivir Phosphate Capsules Description and Business Overview
6.14.3 Qilu Pharmaceutical Oseltamivir Phosphate Capsules Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Qilu Pharmaceutical Oseltamivir Phosphate Capsules Product Portfolio
6.14.5 Qilu Pharmaceutical Recent Developments/Updates
6.15 CSPC
6.15.1 CSPC Corporation Information
6.15.2 CSPC Oseltamivir Phosphate Capsules Description and Business Overview
6.15.3 CSPC Oseltamivir Phosphate Capsules Sales, Revenue and Gross Margin (2018-2023)
6.15.4 CSPC Oseltamivir Phosphate Capsules Product Portfolio
6.15.5 CSPC Recent Developments/Updates
6.16 Zhijun Pingshan
6.16.1 Zhijun Pingshan Corporation Information
6.16.2 Zhijun Pingshan Oseltamivir Phosphate Capsules Description and Business Overview
6.16.3 Zhijun Pingshan Oseltamivir Phosphate Capsules Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Zhijun Pingshan Oseltamivir Phosphate Capsules Product Portfolio
6.16.5 Zhijun Pingshan Recent Developments/Updates
6.17 Zhongxi Sunve
6.17.1 Zhongxi Sunve Corporation Information
6.17.2 Zhongxi Sunve Oseltamivir Phosphate Capsules Description and Business Overview
6.17.3 Zhongxi Sunve Oseltamivir Phosphate Capsules Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Zhongxi Sunve Oseltamivir Phosphate Capsules Product Portfolio
6.17.5 Zhongxi Sunve Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Oseltamivir Phosphate Capsules Industry Chain Analysis
7.2 Oseltamivir Phosphate Capsules Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Oseltamivir Phosphate Capsules Production Mode & Process
7.4 Oseltamivir Phosphate Capsules Sales and Marketing
7.4.1 Oseltamivir Phosphate Capsules Sales Channels
7.4.2 Oseltamivir Phosphate Capsules Distributors
7.5 Oseltamivir Phosphate Capsules Customers
8 Oseltamivir Phosphate Capsules Market Dynamics
8.1 Oseltamivir Phosphate Capsules Industry Trends
8.2 Oseltamivir Phosphate Capsules Market Drivers
8.3 Oseltamivir Phosphate Capsules Market Challenges
8.4 Oseltamivir Phosphate Capsules Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Tables
Table 1. Global Oseltamivir Phosphate Capsules Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Oseltamivir Phosphate Capsules Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Oseltamivir Phosphate Capsules Market Competitive Situation by Manufacturers in 2022
Table 4. Global Oseltamivir Phosphate Capsules Sales (Kg) of Key Manufacturers (2018-2023)
Table 5. Global Oseltamivir Phosphate Capsules Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Oseltamivir Phosphate Capsules Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Oseltamivir Phosphate Capsules Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Oseltamivir Phosphate Capsules Average Price (US$/g) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Oseltamivir Phosphate Capsules, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Oseltamivir Phosphate Capsules, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Oseltamivir Phosphate Capsules, Product Type & Application
Table 12. Global Key Manufacturers of Oseltamivir Phosphate Capsules, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Oseltamivir Phosphate Capsules by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oseltamivir Phosphate Capsules as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Oseltamivir Phosphate Capsules Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Oseltamivir Phosphate Capsules Sales by Region (2018-2023) & (Kg)
Table 18. Global Oseltamivir Phosphate Capsules Sales Market Share by Region (2018-2023)
Table 19. Global Oseltamivir Phosphate Capsules Sales by Region (2024-2029) & (Kg)
Table 20. Global Oseltamivir Phosphate Capsules Sales Market Share by Region (2024-2029)
Table 21. Global Oseltamivir Phosphate Capsules Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Oseltamivir Phosphate Capsules Revenue Market Share by Region (2018-2023)
Table 23. Global Oseltamivir Phosphate Capsules Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Oseltamivir Phosphate Capsules Revenue Market Share by Region (2024-2029)
Table 25. North America Oseltamivir Phosphate Capsules Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Oseltamivir Phosphate Capsules Sales by Country (2018-2023) & (Kg)
Table 27. North America Oseltamivir Phosphate Capsules Sales by Country (2024-2029) & (Kg)
Table 28. North America Oseltamivir Phosphate Capsules Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Oseltamivir Phosphate Capsules Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Oseltamivir Phosphate Capsules Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Oseltamivir Phosphate Capsules Sales by Country (2018-2023) & (Kg)
Table 32. Europe Oseltamivir Phosphate Capsules Sales by Country (2024-2029) & (Kg)
Table 33. Europe Oseltamivir Phosphate Capsules Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Oseltamivir Phosphate Capsules Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Oseltamivir Phosphate Capsules Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Oseltamivir Phosphate Capsules Sales by Region (2018-2023) & (Kg)
Table 37. Asia Pacific Oseltamivir Phosphate Capsules Sales by Region (2024-2029) & (Kg)
Table 38. Asia Pacific Oseltamivir Phosphate Capsules Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Oseltamivir Phosphate Capsules Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Oseltamivir Phosphate Capsules Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Oseltamivir Phosphate Capsules Sales by Country (2018-2023) & (Kg)
Table 42. Latin America Oseltamivir Phosphate Capsules Sales by Country (2024-2029) & (Kg)
Table 43. Latin America Oseltamivir Phosphate Capsules Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Oseltamivir Phosphate Capsules Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Oseltamivir Phosphate Capsules Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Oseltamivir Phosphate Capsules Sales by Country (2018-2023) & (Kg)
Table 47. Middle East & Africa Oseltamivir Phosphate Capsules Sales by Country (2024-2029) & (Kg)
Table 48. Middle East & Africa Oseltamivir Phosphate Capsules Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Oseltamivir Phosphate Capsules Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Oseltamivir Phosphate Capsules Sales (Kg) by Type (2018-2023)
Table 51. Global Oseltamivir Phosphate Capsules Sales (Kg) by Type (2024-2029)
Table 52. Global Oseltamivir Phosphate Capsules Sales Market Share by Type (2018-2023)
Table 53. Global Oseltamivir Phosphate Capsules Sales Market Share by Type (2024-2029)
Table 54. Global Oseltamivir Phosphate Capsules Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Oseltamivir Phosphate Capsules Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Oseltamivir Phosphate Capsules Revenue Market Share by Type (2018-2023)
Table 57. Global Oseltamivir Phosphate Capsules Revenue Market Share by Type (2024-2029)
Table 58. Global Oseltamivir Phosphate Capsules Price (US$/g) by Type (2018-2023)
Table 59. Global Oseltamivir Phosphate Capsules Price (US$/g) by Type (2024-2029)
Table 60. Global Oseltamivir Phosphate Capsules Sales (Kg) by Application (2018-2023)
Table 61. Global Oseltamivir Phosphate Capsules Sales (Kg) by Application (2024-2029)
Table 62. Global Oseltamivir Phosphate Capsules Sales Market Share by Application (2018-2023)
Table 63. Global Oseltamivir Phosphate Capsules Sales Market Share by Application (2024-2029)
Table 64. Global Oseltamivir Phosphate Capsules Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Oseltamivir Phosphate Capsules Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Oseltamivir Phosphate Capsules Revenue Market Share by Application (2018-2023)
Table 67. Global Oseltamivir Phosphate Capsules Revenue Market Share by Application (2024-2029)
Table 68. Global Oseltamivir Phosphate Capsules Price (US$/g) by Application (2018-2023)
Table 69. Global Oseltamivir Phosphate Capsules Price (US$/g) by Application (2024-2029)
Table 70. Natco Pharma Corporation Information
Table 71. Natco Pharma Description and Business Overview
Table 72. Natco Pharma Oseltamivir Phosphate Capsules Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2018-2023)
Table 73. Natco Pharma Oseltamivir Phosphate Capsules Product
Table 74. Natco Pharma Recent Developments/Updates
Table 75. Roche Pharma Corporation Information
Table 76. Roche Pharma Description and Business Overview
Table 77. Roche Pharma Oseltamivir Phosphate Capsules Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2018-2023)
Table 78. Roche Pharma Oseltamivir Phosphate Capsules Product
Table 79. Roche Pharma Recent Developments/Updates
Table 80. HEC Corporation Information
Table 81. HEC Description and Business Overview
Table 82. HEC Oseltamivir Phosphate Capsules Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2018-2023)
Table 83. HEC Oseltamivir Phosphate Capsules Product
Table 84. HEC Recent Developments/Updates
Table 85. Zentiva Corporation Information
Table 86. Zentiva Description and Business Overview
Table 87. Zentiva Oseltamivir Phosphate Capsules Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2018-2023)
Table 88. Zentiva Oseltamivir Phosphate Capsules Product
Table 89. Zentiva Recent Developments/Updates
Table 90. Taj Pharma Corporation Information
Table 91. Taj Pharma Description and Business Overview
Table 92. Taj Pharma Oseltamivir Phosphate Capsules Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2018-2023)
Table 93. Taj Pharma Oseltamivir Phosphate Capsules Product
Table 94. Taj Pharma Recent Developments/Updates
Table 95. Sawai Pharmaceutical Corporation Information
Table 96. Sawai Pharmaceutical Description and Business Overview
Table 97. Sawai Pharmaceutical Oseltamivir Phosphate Capsules Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2018-2023)
Table 98. Sawai Pharmaceutical Oseltamivir Phosphate Capsules Product
Table 99. Sawai Pharmaceutical Recent Developments/Updates
Table 100. MSN Laboratories Corporation Information
Table 101. MSN Laboratories Description and Business Overview
Table 102. MSN Laboratories Oseltamivir Phosphate Capsules Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2018-2023)
Table 103. MSN Laboratories Oseltamivir Phosphate Capsules Product
Table 104. MSN Laboratories Recent Developments/Updates
Table 105. Hetero Healthcare Corporation Information
Table 106. Hetero Healthcare Description and Business Overview
Table 107. Hetero Healthcare Oseltamivir Phosphate Capsules Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2018-2023)
Table 108. Hetero Healthcare Oseltamivir Phosphate Capsules Product
Table 109. Hetero Healthcare Recent Developments/Updates
Table 110. Cipla Corporation Information
Table 111. Cipla Description and Business Overview
Table 112. Cipla Oseltamivir Phosphate Capsules Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2018-2023)
Table 113. Cipla Oseltamivir Phosphate Capsules Product
Table 114. Cipla Recent Developments/Updates
Table 115. Amneal Pharmaceuticals Corporation Information
Table 116. Amneal Pharmaceuticals Description and Business Overview
Table 117. Amneal Pharmaceuticals Oseltamivir Phosphate Capsules Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2018-2023)
Table 118. Amneal Pharmaceuticals Oseltamivir Phosphate Capsules Product
Table 119. Amneal Pharmaceuticals Recent Developments/Updates
Table 120. Brilliant Pharmaceutical Corporation Information
Table 121. Brilliant Pharmaceutical Description and Business Overview
Table 122. Brilliant Pharmaceutical Oseltamivir Phosphate Capsules Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2018-2023)
Table 123. Brilliant Pharmaceutical Oseltamivir Phosphate Capsules Product
Table 124. Brilliant Pharmaceutical Recent Developments/Updates
Table 125. BrightGene Corporation Information
Table 126. BrightGene Description and Business Overview
Table 127. BrightGene Oseltamivir Phosphate Capsules Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2018-2023)
Table 128. BrightGene Oseltamivir Phosphate Capsules Product
Table 129. BrightGene Recent Developments/Updates
Table 130. Kelun Pharmaceutical Corporation Information
Table 131. Kelun Pharmaceutical Description and Business Overview
Table 132. Kelun Pharmaceutical Oseltamivir Phosphate Capsules Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2018-2023)
Table 133. Kelun Pharmaceutical Oseltamivir Phosphate Capsules Product
Table 134. Kelun Pharmaceutical Recent Developments/Updates
Table 135. Qilu Pharmaceutical Corporation Information
Table 136. Qilu Pharmaceutical Description and Business Overview
Table 137. Qilu Pharmaceutical Oseltamivir Phosphate Capsules Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2018-2023)
Table 138. Qilu Pharmaceutical Oseltamivir Phosphate Capsules Product
Table 139. Qilu Pharmaceutical Recent Developments/Updates
Table 140. CSPC Corporation Information
Table 141. CSPC Description and Business Overview
Table 142. CSPC Oseltamivir Phosphate Capsules Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2018-2023)
Table 143. CSPC Oseltamivir Phosphate Capsules Product
Table 144. CSPC Recent Developments/Updates
Table 145. Zhijun Pingshan Corporation Information
Table 146. Zhijun Pingshan Description and Business Overview
Table 147. Zhijun Pingshan Oseltamivir Phosphate Capsules Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2018-2023)
Table 148. Zhijun Pingshan Oseltamivir Phosphate Capsules Product
Table 149. Zhijun Pingshan Recent Developments/Updates
Table 150. Zhongxi Sunve Corporation Information
Table 151. Zhongxi Sunve Description and Business Overview
Table 152. Zhongxi Sunve Oseltamivir Phosphate Capsules Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2018-2023)
Table 153. Zhongxi Sunve Oseltamivir Phosphate Capsules Product
Table 154. Zhongxi Sunve Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Oseltamivir Phosphate Capsules Distributors List
Table 158. Oseltamivir Phosphate Capsules Customers List
Table 159. Oseltamivir Phosphate Capsules Market Trends
Table 160. Oseltamivir Phosphate Capsules Market Drivers
Table 161. Oseltamivir Phosphate Capsules Market Challenges
Table 162. Oseltamivir Phosphate Capsules Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Oseltamivir Phosphate Capsules
Figure 2. Global Oseltamivir Phosphate Capsules Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Oseltamivir Phosphate Capsules Market Share by Type in 2022 & 2029
Figure 4. 30mg Product Picture
Figure 5. 45mg Product Picture
Figure 6. 75mg Product Picture
Figure 7. Global Oseltamivir Phosphate Capsules Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global Oseltamivir Phosphate Capsules Market Share by Application in 2022 & 2029
Figure 9. Influenza Treatment
Figure 10. Influenza Prevention
Figure 11. Global Oseltamivir Phosphate Capsules Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Oseltamivir Phosphate Capsules Market Size (2018-2029) & (US$ Million)
Figure 13. Global Oseltamivir Phosphate Capsules Sales (2018-2029) & (Kg)
Figure 14. Global Oseltamivir Phosphate Capsules Average Price (US$/g) & (2018-2029)
Figure 15. Oseltamivir Phosphate Capsules Report Years Considered
Figure 16. Oseltamivir Phosphate Capsules Sales Share by Manufacturers in 2022
Figure 17. Global Oseltamivir Phosphate Capsules Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Oseltamivir Phosphate Capsules Players: Market Share by Revenue in 2022
Figure 19. Oseltamivir Phosphate Capsules Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global Oseltamivir Phosphate Capsules Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. North America Oseltamivir Phosphate Capsules Sales Market Share by Country (2018-2029)
Figure 22. North America Oseltamivir Phosphate Capsules Revenue Market Share by Country (2018-2029)
Figure 23. U.S. Oseltamivir Phosphate Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Canada Oseltamivir Phosphate Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Europe Oseltamivir Phosphate Capsules Sales Market Share by Country (2018-2029)
Figure 26. Europe Oseltamivir Phosphate Capsules Revenue Market Share by Country (2018-2029)
Figure 27. Germany Oseltamivir Phosphate Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. France Oseltamivir Phosphate Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. U.K. Oseltamivir Phosphate Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Italy Oseltamivir Phosphate Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Russia Oseltamivir Phosphate Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Asia Pacific Oseltamivir Phosphate Capsules Sales Market Share by Region (2018-2029)
Figure 33. Asia Pacific Oseltamivir Phosphate Capsules Revenue Market Share by Region (2018-2029)
Figure 34. China Oseltamivir Phosphate Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Japan Oseltamivir Phosphate Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. South Korea Oseltamivir Phosphate Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. India Oseltamivir Phosphate Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Australia Oseltamivir Phosphate Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Taiwan Oseltamivir Phosphate Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Indonesia Oseltamivir Phosphate Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Thailand Oseltamivir Phosphate Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Malaysia Oseltamivir Phosphate Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Philippines Oseltamivir Phosphate Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Latin America Oseltamivir Phosphate Capsules Sales Market Share by Country (2018-2029)
Figure 45. Latin America Oseltamivir Phosphate Capsules Revenue Market Share by Country (2018-2029)
Figure 46. Mexico Oseltamivir Phosphate Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Brazil Oseltamivir Phosphate Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Argentina Oseltamivir Phosphate Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Middle East & Africa Oseltamivir Phosphate Capsules Sales Market Share by Country (2018-2029)
Figure 50. Middle East & Africa Oseltamivir Phosphate Capsules Revenue Market Share by Country (2018-2029)
Figure 51. Turkey Oseltamivir Phosphate Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Saudi Arabia Oseltamivir Phosphate Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. U.A.E Oseltamivir Phosphate Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Global Sales Market Share of Oseltamivir Phosphate Capsules by Type (2018-2029)
Figure 55. Global Revenue Market Share of Oseltamivir Phosphate Capsules by Type (2018-2029)
Figure 56. Global Oseltamivir Phosphate Capsules Price (US$/g) by Type (2018-2029)
Figure 57. Global Sales Market Share of Oseltamivir Phosphate Capsules by Application (2018-2029)
Figure 58. Global Revenue Market Share of Oseltamivir Phosphate Capsules by Application (2018-2029)
Figure 59. Global Oseltamivir Phosphate Capsules Price (US$/g) by Application (2018-2029)
Figure 60. Oseltamivir Phosphate Capsules Value Chain
Figure 61. Oseltamivir Phosphate Capsules Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • デクスランソプラゾールのグローバル市場展望 2023年-2029年：30mg、60mg
  • イクルシグのグローバル市場展望 2023年-2029年：45mg、15mg
  • イブプロフェンカプセルの世界市場2023年：200mg/個、300mg/個
  • ジクロフェナクナトリウム徐放性カプセルの世界市場2023年：仕様0.25g、仕様0.5g
  • 医療用ソフトカプセルの世界市場2023年：ゼラチンタイプ、ノンアニマルタイプ
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA7522 )"オセルタミビルリン酸塩カプセルの世界市場2023年：30mg、45mg、75mg" (英文：Global Oseltamivir Phosphate Capsules Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。